Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (1y) (2017 - 2026)
Teva Pharmaceutical Industries (TEVA) Net Income towards Common Stockholders Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.00 Bn | 34.26 Bn | 1.97 Bn | 71.83% |
| 2 | Zoetis | 33.47 Bn | 31.53 Bn | 1.62 Bn | -0.17% |
| 3 | United Therapeutics | 23.87 Bn | 21.72 Bn | 648.10 Mn | -14.68% |
| 4 | Neurocrine Biosciences | 15.74 Bn | 14.43 Bn | 800.70 Mn | 2,405.06% |
| 5 | Aurora Cannabis | 15.38 Bn | 15.29 Bn | 21.72 Mn | 174.14% |
| 6 | Elanco Animal Health | 12.06 Bn | 11.63 Bn | 785.00 Mn | -14.93% |
| 7 | Alkermes | 7.32 Bn | 6.81 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 7.17 Bn | 6.42 Bn | 396.79 Mn | -286.15% |
| 9 | Lantheus Holdings | 6.80 Bn | 6.30 Bn | 230.92 Mn | 62.34% |
| 10 | Liquidia | 5.94 Bn | 5.72 Bn | 121.79 Mn | 237.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.83% |
| Dec 31, 2025 | 265.25% |
| Sep 30, 2025 | 160.11% |
| Jun 30, 2025 | 125.37% |
| Mar 31, 2025 | -16.14% |
| Dec 31, 2024 | -83.12% |
| Sep 30, 2024 | -40.71% |
| Jun 30, 2024 | 30.90% |
| Mar 31, 2024 | 125.30% |
| Dec 31, 2023 | 92.76% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | -46.21% |
| Mar 31, 2023 | 46.85% |
| Dec 31, 2022 | -90.51% |
| Sep 30, 2022 | -1.33% |
| Jun 30, 2022 | -37.58% |
| Mar 31, 2022 | -111.53% |
| Dec 31, 2021 | -844.67% |
| Sep 30, 2021 | 84.41% |
| Jun 30, 2021 | -655.00% |